XLXue Liu

Xue Liu

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Xue Liu has a total of 212 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Genome-wide CRISPRi-seq maps essential-gene contributions to aminoglycoside susceptibility in Pseudomonas aeruginosa

    by Weronika Czekała, Jan Gawor, Raymi Edgar Goitia Camacho, Barbara Domańska, Luis Felipe Padilla Martinez, Karolina Żuchniewicz, Filip Pośnik, Aneta Agnieszka Bartosik, Xue Liu, Adam Kawałek

    Pseudomonas aeruginosa is an opportunistic ESKAPE pathogen whose multiple intrinsic and acquired antibiotic resistance mechanisms restrict treatment options. Essential genes offer potential antimicrobial targets, but their vulnerability to partial inhibition and contribution to antibiotic susceptibility remain incompletely characterized. Here, we developed a rhamnose-inducible CRISPR interference (CRISPRi) platform and an 83,078-guide library for genome-wide screening in PAO1, with mismatch guides enabling graded repression. Fitness profiling in antibiotic-free Mueller–Hinton medium identified 743 genes whose repression reduced competitive fitness and revealed sequence features associated with guide performance. Combining full-match and mismatch-guide responses revealed substantial variation in essential-gene fitness effects across predicted repression strengths, while comparison of fitness profiles between Mueller–Hinton medium and fetal bovine serum identified condition-dependent effects alongside a conserved fitness landscape. Under aminoglycoside exposure, we identified 118 recurrent sensitizing and 120 recurrent protective gene knockdowns, including many targeting essential and fitness-associated functions. Growth and killing assays with individual strains confirmed that CRISPRi targeting of atpI , accC , secA and ftsZ enhanced tobramycin activity. Finally, transcriptome analysis of these knockdowns confirmed target silencing, captured polar effects on neighboring genes and revealed distinct but overlapping transcriptional responses. Together, these findings quantify the variable fitness costs of essential-gene repression and identify candidate targets for potentiating aminoglycoside activity. IMPORTANCE: Essential bacterial genes are difficult to study because their complete disruption prevents growth. Yet knowing that a gene is essential does not reveal how strongly its activity must be reduced to impair growth. Here, we developed a method to examine how reduced gene expression affects fitness across the genome of Pseudomonas aeruginosa , a major cause of difficult-to-treat infections. This approach identified essential functions particularly vulnerable to partial depletion and mapped how gene repression alters aminoglycoside susceptibility. Repressing selected genes impaired growth and disproportionately increased killing by tobramycin. These tools and datasets provide a resource for prioritizing candidate antibacterial targets and investigating whether partial inhibition of essential functions can enhance the activity of existing antibiotics.

  • Open Access

    Multi-omics profiling reveals atypical sugar utilization and a key membrane composition regulator in Streptococcus pneumoniae

    by Vincent de Bakker, Xue Liu, Jonah Tang, Matthew Barbisan, Jonathon L. Baker, Jan-Willem Veening

    The human body comprises many different microenvironments, each with their own challenges for microorganisms to overcome in order to survive and possibly cause infection. The human pathogen Streptococcus pneumoniae is notoriously flexible in this regard, and can adapt to a wide range of host niches, including the nasopharynx, lungs, and cerebrospinal fluid. However, the molecular and genetic foundation of this ability remain largely uncharted. In this work, we demonstrate that niche adaptation imposes genome-wide changes on multiple levels, including gene essentiality, expression and membrane lipid composition, by using infection-mimicking growth conditions. In general, we show that gene expression and fitness profiling couple orthogonal sets of genes to environmental stimuli. For instance, import ( manLMN ) and catabolism ( nagAB ) genes are required, but not differentially expressed during growth on N-acetylglucosamine (GlcNAc), opposite to the pattern of other amino sugar metabolism pathways. Surprisingly, we find that pneumococci do not necessarily prefer glucose over GlcNAc and that uptake of GlcNAc in absence of subsequent catabolism is toxic. Moreover, we identify a previously overlooked fatty acid saturation regulator, FasR, controlling membrane composition, rendering it important during heat stress. As nutrient availability and temperature fluctuations are distinctive facets of infection environments, these findings may inform anti-infective strategies.


  • Open Access

    Dual CRISPRi-seq for genome-wide genetic interaction studies identifies key genes involved in the pneumococcal cell cycle

    by Julien Dénéréaz, Elise Eray, Bimal Jana, Vincent de Bakker, Horia Todor, Tim van Opijnen, Xue Liu, Jan-Willem Veening


  • Open Access

    CRISPRi screen identifies FprB as a synergistic target for gallium therapy in Pseudomonas aeruginosa

    by Yu Zhang, Tingting Zhang, Xue Xiao, Yejun Wang, Adam Kawalek, Jinzhao Ou, Anmin Ren, Wenhao Sun, Vincent de Bakker, Yujie Liu, et al.

    With the rise of antibiotic-resistant bacteria, non-antibiotic therapies like gallium gain increasing attention. Intravenous gallium nitrate is under Phase II clinical trials to treat chronic Pseudomonas aeruginosa infections in cystic fibrosis patients. However, its clinical efficacy is constrained by the achievable peak concentration in human tissue. To address this limitation, we apply a genome-wide CRISPR interference approach (CRISPRi-seq) to identify potential synergistic targets with gallium. We classify the essential genes by response time and growth reduction, pinpointing the most vulnerable therapeutic targets in this species. In addition, we identify a highly conserved gene, fprB, encoding a ferredoxin-NADP⁺ reductase, whose deletion sensitizes P. aeruginosa to gallium, lowering its MIC by 32-fold and shifting mode of action from bacteriostatic to bactericidal. Further investigation reveals that FprB plays a critical role in modulating oxidative stress induced by gallium, via control of iron homeostasis and reactive oxygen species accumulation. Deleting fprB enhances gallium’s efficacy against biofilm formation and improves outcomes in a murine lung infection model of P. aeruginosa, suggesting FprB is a promising drug target in combination with gallium. Overall, our data show CRISPRi-seq as a powerful tool for systematic genetic analysis of P. aeruginosa, advancing the identification of novel therapeutic targets.


  • Top Cited Papers

    Bacterial reverse transcriptase synthesizes long poly(A)-rich cDNA for antiphage defense

    by Xin-Yi Song, Yushan Xia, Jun-Tao Zhang, Yu-Jun Liu, Hua Qi, Xin-Yang Wei, Hailiang Hu, Yu Xia, Xue Liu, Ying-Fei Ma, et al.

    Prokaryotic defense-associated reverse transcriptases (DRTs) were recently identified with antiviral functions; however, their functional mechanisms remain largely unexplored. Here we show that DRT9 forms a hexameric complex with its upstream noncoding RNA (ncRNA) to mediate antiphage defense by inducing cell growth arrest through abortive infection. Upon phage infection, the phage-encoded ribonucleotide reductase NrdAB complex increases intracellular deoxyadenosine triphosphate levels, activating DRT9 to synthesize long, polyadenylate [poly(A)]–rich single-stranded complementary DNA (cDNA), which likely sequesters the essential phage single-stranded DNA binding (SSB) protein and disrupts phage propagation. We further determined the cryo–electron microscopy structure of the DRT9-ncRNA hexamer complex, providing mechanistic insights into its cDNA synthesis. These findings highlight the diversity of RT-based antiviral defense mechanisms, expand our understanding of RT biological functions, and provide a structural basis for developing DRT9-based biotechnological tools.


  • Open Access

    Multi-omics profiling reveals atypical sugar utilization and identifies a key membrane composition regulator in Streptococcus pneumoniae

    by Vincent de Bakker, Xue Liu, Jonah Tang, Matthew Barbisan, Jonathon L. Baker, Jan-Willem Veening

    The human body comprises many different microenvironments, each with their own challenges for microorganisms to overcome in order to survive, and possibly cause infection. The human pathogen Streptococcus pneumoniae is notoriously flexible in this regard, and can adapt to a wide range of host niches, including the nasopharynx, lungs, and cerebrospinal fluid. However, the molecular and genetic underpinnings of this ability remain largely obscure. In this work, using infection-mimicking growth conditions we demonstrate that niche adaptation imposes genome-wide changes on multiple levels, including gene essentiality, expression and membrane lipid composition. In general, we show that gene expression and fitness profiling couple orthogonal sets of genes to environmental stimuli. For instance, N-acetylglucosamine (GlcNAc) import ( manLMN ) and catabolism ( nagAB ) genes were required for growth on this sugar, but not differentially expressed in its presence, whereas other amino sugar metabolism pathways were upregulated, but not essential. Surprisingly, we found that pneumococci do not necessarily prefer glucose over GlcNAc and that uptake of GlcNAc in absence of subsequent catabolism was toxic. Moreover, we identified a previously overlooked fatty acid saturation regulator, FasR, controlling membrane composition, rendering it important during heat stress. A fundamental understanding of how genes contribute to bacterial niche adaptation, including nutrient availability or temperature fluctuations, is crucial for understanding successful antibiotic therapy and vaccination strategies and the development of novel anti-infectives.


  • Open Access

    Make-or-break prime editing for genome engineering in Streptococcus pneumoniae

    by Monica Rengifo-Gonzalez, Maria-Vittoria Mazzuoli, Axel B. Janssen, Anne-Stéphanie Rueff, Jessica Burnier, Xue Liu, Jan-Willem Veening

    CRISPR-Cas9 has revolutionized genome engineering by allowing precise introductions of DNA double-strand breaks (DSBs). However, genome engineering in bacteria is still a complex, multi-step process requiring a donor DNA template for repair of DSBs. Prime editing circumvents this need as the repair template is indirectly provided within the prime editing guide RNA (pegRNA). Here, we developed make-or-break Prime Editing (mbPE) that allows for precise and effective genetic engineering in the opportunistic human pathogen Streptococcus pneumoniae. In contrast to traditional prime editing in which a nicking Cas9 is employed, mbPE harnesses wild type Cas9 in combination with a pegRNA that destroys the seed region or protospacer adjacent motif. Since most bacteria poorly perform template-independent end joining, correctly genome-edited clones are selectively enriched during mbPE. We show that mbPE is RecA-independent and can be used to introduce point mutations, deletions and targeted insertions, including protein tags such as a split luciferase, at selection efficiencies of over 93%. mbPE enables sequential genome editing, is scalable, and can be used to generate pools of mutants in a high-throughput manner. The mbPE system and pegRNA design guidelines described here will ameliorate future bacterial genome editing endeavors.


  • Open Access

    Genome-wide analysis of fitness determinants of Staphylococcus aureus during growth in milk

    by Marita Torrissen Mårli, Anne Olsdatter Ohren Nordraak, Vincent de Bakker, Anja Ruud Winther, Xue Liu, Jan-Willem Veening, Davide Porecellato, Morten Kjos

    Staphylococcus aureus is a major concern in the dairy industry due to its significance as a pathogen causing bovine mastitis as well as a source of food poisoning. The nutrient-rich milk environment supports bacterial growth, but the specific genetic determinants that facilitate S. aureus proliferation and persistence in milk are poorly understood. In this study, we conducted a genome-wide CRISPR interference sequencing (CRISPRi-seq) screen to identify fitness determinants essential for S. aureus growth and survival in milk. We identified 282 milk-essential genes, including those with key roles in DNA replication, protein synthesis, and metabolism. Comparative analysis with brain heart infusion (BHI) as growth medium, revealed 79 genes with differential fitness, highlighting specific adaptations required for growth in milk. Notably, we found that purine biosynthesis, folate cycle pathways, and metal acquisition were particularly important in this environment. Based on this, we further demonstrate that S. aureus is more sensitive to the folate inhibitors trimethoprim-sulfamethoxazole (TMP-SMX) in milk and identify several genes whose knockdown results in hypersensitivity to TMP-SMX in milk. Additionally, our analysis showed a relatively reduced importance of cell wall components, such as teichoic acids, for S. aureus fitness in milk, which is also reflected in reduced efficiency of antimicrobials targeting teichoic acids. Together, these findings provide new insights into the genetic basis of S. aureus fitness and antibiotic susceptibility in milk, offering directions for novel treatment strategies against bovine mastitis.


  • Open Access

    Genome-wide CRISPRi-seq identified ferredoxin-NADP reductase FprB as a synergistic target for gallium therapy in Pseudomonas aeruginosa

    by Xue Liu, Yu Zhang, Tingting Zhang, Xue Xiao, Adam Kawalek, Jinzhao Ou, Anmin Ren, Wenhao Sun, Vincent de Bakker, Yujie Liu, et al.

    With the rise of antibiotic-resistant bacteria, non-antibiotic therapies like gallium are increasingly gaining attention. Gallium ions exhibit potent activity against multidrug-resistant bacteria and intravenous gallium nitrite is under phase 2 clinical trials to treat chronic Pseudomonas aeruginosa infections in cystic fibrosis patients. However, its clinical efficacy is constrained by the achievable peak concentration in human tissue. To address this limitation, we applied a genome-wide CRISPR interference approach (CRISPRi-seq), to identify potential synergistic targets with gallium. Through the systemic screening, we classified the essential genes by response time and growth reduction, pinpointing the most vulnerable therapeutic targets in this species. In addition, we identified a highly conserved gene fprB, encoding a ferredoxin-NADP+ reductase, the downregulation of which dramatically sensitized the cells to gallium. Using a null mutant, we confirmed the loss of fprB lowers the minimum inhibitory concentration of gallium from 320 µM to 10 µM and shifted gallium’s mode of action from bacteriostatic to bactericidal. Further investigation revealed that FprB plays a critical role in modulating oxidative stress induced by gallium, via control of the iron homeostasis and reactive oxygen species accumulation. Deleting fprB also enhanced gallium's efficacy against biofilms formation and improved outcomes in murine lung infection model of P. aeruginosa, suggesting FprB as a promising drug target in combination with gallium. Overall, our data showed CRISPRi-seq as a powerful tool for systematic genetic analysis of P. aeruginosa, advancing identification of novel therapeutic targets.

  • Open Access

    Genome-wide CRISPRi-seq identified ferredoxin-NADP reductase FprB as a synergistic target for gallium therapy in Pseudomonas aeruginosa

    by Yu Zhang, Tingting Zhang, Xue Xiao, Adam Kawalek, Jinzhao Ou, Anmin Ren, Wenhao Sun, Vincent de Bakker, Yujie Liu, Yuelong Li, et al.

    With the rise of antibiotic-resistant bacteria, non-antibiotic therapies like gallium are increasingly gaining attention. Gallium ions exhibit potent activity against multidrug-resistant bacteria and intravenous gallium nitrite is under phase 2 clinical trials to treat chronic Pseudomonas aeruginosa infections in cystic fibrosis patients. However, its clinical efficacy is constrained by the achievable peak concentration in human tissue. To address this limitation, we applied a genome-wide CRISPR interference approach (CRISPRi-seq), to identify potential synergistic targets with gallium. Through the systemic screening, we classified the essential genes by response time and growth reduction, pinpointing the most vulnerable therapeutic targets in this species. In addition, we identified a highly conserved gene fprB , encoding a ferredoxin-NADP + reductase, the downregulation of which dramatically sensitized the cells to gallium. Using a null mutant, we confirmed the loss of fprB lowers the minimum inhibitory concentration of gallium from 320 µM to 10 µM and shifted gallium’s mode of action from bacteriostatic to bactericidal. Further investigation revealed that FprB plays a critical role in modulating oxidative stress induced by gallium, via control of the iron homeostasis and reactive oxygen species accumulation. Deleting fprB also enhanced gallium’s efficacy against biofilms formation and improved outcomes in murine lung infection model of P. aeruginosa, suggesting FprB as a promising drug target in combination with gallium. Overall, our data showed CRISPRi-seq as a powerful tool for systematic genetic analysis of P. aeruginosa , advancing identification of novel therapeutic targets.